Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

Blue I think some of us been here a long time and I remember we did look at the pipeline at one point and looked at all the competitions out there as well as patents expiring.

I think we looked at the price of each that's selling on the market and cheap pills selling at high quantities means you're going to be producing a whole lot and your cost in production and shipping can go up. That cuts into your potential profit when you have to compete and sell lower price. It would be less desirable for a potential partner.

Metformin Glocophage for example, our partner MNK already producing their own version so there is no point in them picking up IPCI version unless IPCI version offers an advantage. Now, if IPCI had gotten approval sooner, perhaps MNK would be producing IPCI version today instead. That's why I said missed opportunity.

I don't remember all the details of our discussions, but if you really want to get an idea. Go and take a look at each of other generics and search about existing manufacturers out there and you'll get an idea how desirable it maybe for a potential partner to be manufacturing or partner with IPCI.